Three Biotech Stocks May Soar?

Three Biotech Stocks May Soar?

Motley Fool poses the provocative question for Amarin, CRISPR Therapeutics and Geron. See below for the George Budwell piece. With numerous clinical and regulatory catalysts on the near-term horizon, biotech stocks should finish the year in strong fashion. This month,...

Pin It on Pinterest